Denali Therapeutics Inc. (DNLI)
NASDAQ: DNLI
· Real-Time Price · USD
14.71
0.25 (1.73%)
At close: Aug 15, 2025, 3:59 PM
14.60
-0.71%
After-hours: Aug 15, 2025, 07:56 PM EDT
Denali Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -479.03M | -453.94M | -422.77M | -427.49M | -419.65M | -137.25M | -145.22M | -124.43M | -128.38M | -370.55M | -325.99M | -302.57M | -283.86M | -285.76M | -290.58M | 29.57M | 55.92M | 57.86M |
Depreciation & Amortization | 11.29M | 9.28M | 8.23M | 8.55M | 8.5M | 8.84M | 16.73M | 18.64M | 18.56M | 18.35M | 10.38M | 8.39M | 8.43M | 8.56M | 8.59M | 8.62M | 8.59M | 8.53M |
Stock-Based Compensation | 100.48M | 100.2M | 102.88M | 103.79M | 106.39M | 107.86M | 108.1M | 107.3M | 104.42M | 101.79M | 99.85M | 96.75M | 93.16M | 90.36M | 85.25M | 76.99M | 69.25M | 60.59M |
Other Working Capital | 37.61M | 6.27M | 9.12M | 7.78M | -21.01M | -326.68M | -292.36M | -297.92M | -278.33M | 28.78M | -26.3M | -44.66M | -46.49M | -56.9M | -24.12M | 246.26M | 271.65M | 295.59M |
Other Non-Cash Items | -16.89M | -411K | 10.04M | 35.72M | 37.81M | 22.86M | 8.61M | -14.53M | -15.08M | -14.5M | -4.92M | -1.79M | -1.06M | -1.45M | -2.98M | -2.87M | -2.72M | -3.28M |
Deferred Income Tax | n/a | n/a | n/a | -32.42M | -44.75M | -56.28M | -56.28M | -23.86M | -11.53M | n/a | n/a | 2.43M | 5.09M | 7.59M | 8.75M | 7.45M | 4.74M | 1.82M |
Change in Working Capital | 34.52M | 4.43M | 10.55M | 5.85M | -22.53M | -327.31M | -289.93M | -295.12M | -269.67M | 33.51M | -24.03M | -40.75M | -43.7M | -52.57M | -20.41M | 248.27M | 273.77M | 294.88M |
Operating Cash Flow | -349.62M | -365.54M | -347.69M | -362.64M | -390.86M | -412.81M | -357.99M | -332M | -301.68M | -231.41M | -244.72M | -237.55M | -221.94M | -233.26M | -211.39M | 368.02M | 409.54M | 420.4M |
Capital Expenditures | -18.33M | -18.84M | -15.91M | -13.05M | -11.24M | -12.3M | -12.94M | -15.55M | -19.54M | -16.58M | -17.83M | -16.04M | -11.86M | -9.74M | -8.5M | -6.64M | -5.47M | -5.02M |
Cash Acquisitions | n/a | n/a | n/a | -75.28M | -178.26M | -352.18M | -262.25M | -64.25M | 17.25M | 99.65M | 9.72M | -112.99M | -91.52M | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -412.09M | -533.73M | -1.23B | -1.47B | -1.87B | -2.12B | -1.81B | -1.89B | -1.51B | -1.27B | -1.12B | -859.78M | -1.08B | -1.32B | -1.42B | -1.79B | -1.81B | -1.6B |
Sales Maturities Of Investments | 872.97M | 935.75M | 1.16B | 1.3B | 1.7B | 2.03B | 2.08B | 1.95B | 1.49B | 1.17B | 991.49M | 821.24M | 969.96M | 1.22B | 1.41B | 1.45B | 1.31B | 965.16M |
Other Investing Acitivies | n/a | 103.36M | -347.68M | -272.4M | -169.42M | -98.86M | 262.25M | 64.25M | -17.25M | -99.65M | -123.55M | -38.54M | -111.14M | -104.36M | -13.13M | -341.57M | -501.86M | -630.26M |
Investing Cash Flow | 442.55M | 383.18M | -88.76M | -187.92M | -180.66M | -111.16M | 249.31M | 48.7M | -36.79M | -116.22M | -141.39M | -54.58M | -123M | -114.1M | -21.63M | -348.22M | -507.33M | -635.28M |
Debt Repayment | -12.68M | -12.68M | -8.32M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -12.19M | -7.05M | -6.63M | -6.08M | 14.97M | 17.24M | 17.82M | 312.77M | 315.43M | 310.81M | 310.67M | 16.19M | 14.35M | 16.99M | 19.35M | 23.7M | 26.14M | 22.51M |
Financial Cash Flow | -24.87M | -19.73M | 484.3M | 493.18M | 514.23M | 516.49M | 17.82M | 312.77M | 315.43M | 310.81M | 310.67M | 16.19M | 14.35M | 16.99M | 19.35M | 23.7M | 446.29M | 442.66M |
Net Cash Flow | 68.06M | -2.1M | 47.85M | -57.38M | -57.29M | -7.48M | -90.86M | 29.47M | -23.04M | -36.82M | -75.43M | -275.94M | -330.59M | -330.37M | -213.67M | 43.51M | 348.5M | 227.78M |
Free Cash Flow | -367.95M | -384.38M | -363.61M | -375.69M | -402.1M | -425.11M | -370.93M | -347.55M | -321.21M | -247.99M | -262.55M | -253.58M | -233.8M | -243M | -219.89M | 361.38M | 404.07M | 415.39M |